Table 1 Clinical characteristics of studied population (n = 108)
From: A cohort study of membranous nephropathy, primary or secondary
Parameter | p value | |
|---|---|---|
Age (years) | 44.21±13.32 | |
Gender (male) | 66 (61.1%) | |
Diabetes | 11 (10.2%) | |
HTN | 68 (63%) | |
Immunosuppressive treatment | ACEi/ARB administration | 91(84.3%) |
PDN + CNI | 61 (59.2%) | |
PDN + CNI + MMF | 9 (8.7%) | |
Rituximab | 2 (1.9%) | |
Ponticelli regimen | 10 (9.7%) | |
PDN | 7 (6.8%) | |
None | 14 (13.6%) |